Obstructive sleep apnoea and polycystic ovary syndrome: a comprehensive review of clinical interactions and underlying pathophysiology

Hassan Kahal, Ioannis Kyrou, Abd A. Tahrani, Harpal S. Randeva*

*Corresponding author for this work

Research output: Contribution to journalArticle

Abstract

Polycystic ovary syndrome (PCOS) is the most prevalent endocrine disorder in women of reproductive age. PCOS is associated with multiple comorbidities including, obesity, insulin resistance and type 2 diabetes, as well as mood disorders and impaired quality of life (QoL). Obstructive sleep apnoea (OSA) is also a common medical condition that is often undiagnosed, particularly in women. OSA is associated with a similar spectrum of comorbidities to that observed in PCOS, including manifestations of the metabolic syndrome and impaired QoL, whilst obesity frequently constitutes a common denominator in the pathophysiology of both OSA and PCOS. Hence, it is not surprising that OSA and PCOS may coexist in women of reproductive age, and the current clinical guidelines on the management of PCOS recommend screening for OSA symptoms in overweight/obese women with PCOS. In this review, we examine the relationship between OSA and PCOS and explore the potential underlying mechanisms that link these two conditions.

Original languageEnglish
Pages (from-to)313-319
JournalClinical Endocrinology
Volume87
Issue number4
Early online date22 Jun 2017
DOIs
Publication statusE-pub ahead of print - 22 Jun 2017

Fingerprint

Polycystic Ovary Syndrome
Obstructive Sleep Apnea
Comorbidity
Obesity
Quality of Life
Mood Disorders
Type 2 Diabetes Mellitus
Insulin Resistance
Guidelines

Keywords

  • hyperandrogenism
  • insulin resistance
  • obesity
  • obstructive sleep apnoea
  • polycystic ovary syndrome

Cite this

@article{0698507e479c4450a6c777a6d4fef55b,
title = "Obstructive sleep apnoea and polycystic ovary syndrome: a comprehensive review of clinical interactions and underlying pathophysiology",
abstract = "Polycystic ovary syndrome (PCOS) is the most prevalent endocrine disorder in women of reproductive age. PCOS is associated with multiple comorbidities including, obesity, insulin resistance and type 2 diabetes, as well as mood disorders and impaired quality of life (QoL). Obstructive sleep apnoea (OSA) is also a common medical condition that is often undiagnosed, particularly in women. OSA is associated with a similar spectrum of comorbidities to that observed in PCOS, including manifestations of the metabolic syndrome and impaired QoL, whilst obesity frequently constitutes a common denominator in the pathophysiology of both OSA and PCOS. Hence, it is not surprising that OSA and PCOS may coexist in women of reproductive age, and the current clinical guidelines on the management of PCOS recommend screening for OSA symptoms in overweight/obese women with PCOS. In this review, we examine the relationship between OSA and PCOS and explore the potential underlying mechanisms that link these two conditions.",
keywords = "hyperandrogenism, insulin resistance, obesity, obstructive sleep apnoea, polycystic ovary syndrome",
author = "Hassan Kahal and Ioannis Kyrou and Tahrani, {Abd A.} and Randeva, {Harpal S.}",
year = "2017",
month = "6",
day = "22",
doi = "10.1111/cen.13392",
language = "English",
volume = "87",
pages = "313--319",
journal = "Clinical Endocrinology",
issn = "0300-0664",
publisher = "Wiley-Blackwell",
number = "4",

}

Obstructive sleep apnoea and polycystic ovary syndrome : a comprehensive review of clinical interactions and underlying pathophysiology. / Kahal, Hassan; Kyrou, Ioannis; Tahrani, Abd A.; Randeva, Harpal S.

In: Clinical Endocrinology, Vol. 87, No. 4, 22.06.2017, p. 313-319.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Obstructive sleep apnoea and polycystic ovary syndrome

T2 - a comprehensive review of clinical interactions and underlying pathophysiology

AU - Kahal, Hassan

AU - Kyrou, Ioannis

AU - Tahrani, Abd A.

AU - Randeva, Harpal S.

PY - 2017/6/22

Y1 - 2017/6/22

N2 - Polycystic ovary syndrome (PCOS) is the most prevalent endocrine disorder in women of reproductive age. PCOS is associated with multiple comorbidities including, obesity, insulin resistance and type 2 diabetes, as well as mood disorders and impaired quality of life (QoL). Obstructive sleep apnoea (OSA) is also a common medical condition that is often undiagnosed, particularly in women. OSA is associated with a similar spectrum of comorbidities to that observed in PCOS, including manifestations of the metabolic syndrome and impaired QoL, whilst obesity frequently constitutes a common denominator in the pathophysiology of both OSA and PCOS. Hence, it is not surprising that OSA and PCOS may coexist in women of reproductive age, and the current clinical guidelines on the management of PCOS recommend screening for OSA symptoms in overweight/obese women with PCOS. In this review, we examine the relationship between OSA and PCOS and explore the potential underlying mechanisms that link these two conditions.

AB - Polycystic ovary syndrome (PCOS) is the most prevalent endocrine disorder in women of reproductive age. PCOS is associated with multiple comorbidities including, obesity, insulin resistance and type 2 diabetes, as well as mood disorders and impaired quality of life (QoL). Obstructive sleep apnoea (OSA) is also a common medical condition that is often undiagnosed, particularly in women. OSA is associated with a similar spectrum of comorbidities to that observed in PCOS, including manifestations of the metabolic syndrome and impaired QoL, whilst obesity frequently constitutes a common denominator in the pathophysiology of both OSA and PCOS. Hence, it is not surprising that OSA and PCOS may coexist in women of reproductive age, and the current clinical guidelines on the management of PCOS recommend screening for OSA symptoms in overweight/obese women with PCOS. In this review, we examine the relationship between OSA and PCOS and explore the potential underlying mechanisms that link these two conditions.

KW - hyperandrogenism

KW - insulin resistance

KW - obesity

KW - obstructive sleep apnoea

KW - polycystic ovary syndrome

UR - http://onlinelibrary.wiley.com/doi/10.1111/cen.13392/abstract

UR - http://www.scopus.com/inward/record.url?scp=85023594720&partnerID=8YFLogxK

U2 - 10.1111/cen.13392

DO - 10.1111/cen.13392

M3 - Article

AN - SCOPUS:85023594720

VL - 87

SP - 313

EP - 319

JO - Clinical Endocrinology

JF - Clinical Endocrinology

SN - 0300-0664

IS - 4

ER -